Dabigatran has the upper hand on warfarin

 

Editorial Focus on Sun et al. Thromb Haemost 2013; 110: 153-161.

• References

• 1 Deedwania P, Huang G. An update on antithrombotic therapy in atrial fibrillation: The role of newer and emergent drugs. Rev Cardiovasc Med 2012; 13: 104.
• 2 Connolly S, Ezekowitz M, Yusuf S. et al. Committee R-LS, Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. New Engl J Med 2009; 361: 1139-1151.
• 3 Watanabe M, Siddiqui F, Qureshi A. Incidence and management of ischemic stroke and intracerebral hemorrhage in patients on dabigatran etexilate treatment. Neurocritical Care 2012; 16: 203-209.
• 4 Sun L, Zhou W, Ploen R. et al. Anticoagulation with dabigatran does not increase secondary intracerebral haemorrhage after thrombolysis in experimental cerebral ischaemia. Thromb Haemost 2013; 110: 153-161.